Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients.pdf

下载文档

9
0
约4.95万字
约 12页
2017-04-09 发布于江苏
举报
版权申诉
保障服务

Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients.pdf

1、本文档共12页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients

n engl j med 361;17 october 22, 2009 1627 The new england journal of medicine established in 1812 october 22, 2009 vol. 361 no. 17 Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients The RENAL Replacement Therapy Study Investigators* A bs tr ac t The Randomized Evaluation of Normal versus Augmented Level (RENAL) Re- placement Therapy Study is a collabora- tion of the Australian and New Zealand Intensive Care Society Clinical Trials Group and the George Institute for Inter- national Health. The members of the Writ- ing Committee for the RENAL Replace- ment Therapy Study (Rinaldo Bellomo, M.D., Alan Cass, M.D., Ph.D., Louise Cole, M.D., Ph.D., Simon Finfer, M.D., Martin Gallagher, M.D., Serigne Lo, Ph.D., Colin McArthur, M.D., Shay McGuinness, M.D., John Myburgh, M.D., Ph.D., Robyn Nor- ton, M.D., Ph.D., M.P.H., Carlos Scheink- estel, M.D., and Steve Su, Ph.D.) take re- sponsibility for the content of this article. Address reprint requests to Dr. Bellomo at ANZICS CTG, Level 3, 10 Ievers St., Carlton, VIC 3053, Australia, or at ctg@ .au. *The members of the Randomized Evalu- ation of Normal versus Augmented Level (RENAL) Replacement Therapy Study Group and their affiliations are listed in the Appendix. N Engl J Med 2009;361:1627-38. Copyright ? 2009 Massachusetts Medical Society. Background The optimal intensity of continuous renal-replacement therapy remains unclear. We conducted a multicenter, randomized trial to compare the effect of this therapy, de- livered at two different levels of intensity, on 90-day mortality among critically ill patients with acute kidney injury. Methods We randomly assigned critically ill adults with acute kidney injury to continuous re- nal-replacement therapy in the form of postdilution continuous venovenous hemo- diafiltration with an effluent flow of either 40 ml per kilogram of body weight per hour (higher intensity) or 25 ml per kilogram per hour (lower intensity). The primary outcome